Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Theranostics in Soft Tissue Sarcoma (ThernSarc)
NCT05420727Phase 1Completed
- Start
- Feb 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of lutetium Lu 177 PSMA I&T in soft tissue sarcoma (STS). Primary endpoint: Imaging result obtained by Ga-68-PSMA-11 PET/CT at 10 weeks. Started Feb 2023; status: completed.
02
Drugs
lutetium Lu 177 PSMA I&T
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT05420727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05420727.